seqWell

Founded to revolutionize DNA sequencing, seqWell focuses on transformative NGS library prep technology. Its core mission is to unlock the full potential of modern DNA sequencing instruments through innovative solutions. The company's flagship product, the plexWell™ platform, enables simple and scalable multiplexing of hundreds to thousands of samples, significantly reducing time and cost. seqWell targets various applications including plasmid and amplicon sequencing, gene editing QC, low-pass WGS, microbial sequencing, and viral sequencing.

Notable figures associated with seqWell include key scientists and industry experts who drive innovation in genomic technologies. The company has attracted significant investment from leading venture capital firms, underscoring its potential impact on the genomics field. Key achievements include the successful development and commercialization of multiple library prep kits such as ExpressPlex™ and purePlex™, which have been widely adopted in research and clinical settings. Overall, seqWell's advancements have streamlined DNA sequencing workflows, making high-throughput sequencing more accessible and efficient.